IHH Healthcare Bhd
KLSE:IHH
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.8
7.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IHH stock under the Base Case scenario is 7.26 MYR. Compared to the current market price of 7.19 MYR, IHH Healthcare Bhd is Undervalued by 1%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
IHH Healthcare Bhd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IHH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
IHH Healthcare Bhd is a premier healthcare provider in Asia, known for its commitment to delivering quality medical services across multiple countries including Malaysia, Singapore, Turkey, and India. Established in 1990, the company has grown significantly through strategic acquisitions and organic expansion, becoming one of the largest healthcare operators globally. Its diverse portfolio encompasses hospitals, medical centers, and clinics that provide a comprehensive range of healthcare services, from advanced tertiary care to outpatient services. Investors are drawn to IHH for its robust growth potential, strong market position, and its ability to tap into the increasing healthcare demand...
IHH Healthcare Bhd is a premier healthcare provider in Asia, known for its commitment to delivering quality medical services across multiple countries including Malaysia, Singapore, Turkey, and India. Established in 1990, the company has grown significantly through strategic acquisitions and organic expansion, becoming one of the largest healthcare operators globally. Its diverse portfolio encompasses hospitals, medical centers, and clinics that provide a comprehensive range of healthcare services, from advanced tertiary care to outpatient services. Investors are drawn to IHH for its robust growth potential, strong market position, and its ability to tap into the increasing healthcare demand driven by an aging population and rising middle class across Asia.
The company's operational excellence is backed by a diverse revenue stream, primarily generated from inpatient and outpatient services, diagnostic services, and healthcare-related products. IHH Healthcare is not only focused on expansion but also invests heavily in technology and innovative healthcare solutions, which enhances efficiency and patient care. With a proven track record of financial performance, characterized by steady revenue growth and a solid balance sheet, IHH Healthcare presents a compelling investment opportunity. For investors looking for exposure in the resilient and rapidly evolving healthcare sector, IHH stands out as a leader with a vision to elevate global healthcare standards while delivering sustainable returns.
IHH Healthcare Berhad is one of the largest healthcare companies in the world, primarily operating across Asia, and it has a diverse range of core business segments. The main segments include:
-
Hospital Operations:
- This segment comprises a network of hospitals that provide a variety of medical services, including inpatient and outpatient care. IHH operates hospitals under multiple brands, including Gleneagles, Mount Elizabeth, and Parkway, catering to different market segments.
-
Healthcare Support Services:
- IHH offers a range of ancillary services that support its hospital operations. These include laboratory services, diagnostic imaging, pharmacy services, and other healthcare-related services that enhance patient care.
-
Medical Education & Training:
- Through its affiliations with medical schools and training institutions, IHH is involved in medical education and training. This segment is vital for ensuring a steady pipeline of skilled healthcare professionals and aligning with industry standards.
-
Senior Living Solutions:
- As part of its strategy to provide comprehensive healthcare services, IHH has also ventured into senior living facilities, offering services tailored for the elderly population, including assisted living and rehabilitation services.
-
International Expansion:
- IHH is focused on expanding its footprint beyond its home markets in Malaysia and Singapore. This includes investments in hospital operations and healthcare services in countries like Turkey, India, and China.
-
Digital Health Innovations:
- IHH is increasingly investing in digital health technologies, including telemedicine and health information systems, to enhance patient experience and operational efficiencies.
These segments work together to create a comprehensive healthcare ecosystem, positioning IHH to meet the diverse needs of patients and healthcare markets across different regions. As always, a fundamental analysis of these segments should consider market trends, competitive landscape, and regulatory environments to assess strategic growth and sustainability.
IHH Healthcare Bhd, one of the largest healthcare providers in Asia, has several unique competitive advantages that allow it to stand out in the crowded healthcare sector. Here are some of the key factors:
-
Extensive Network and Scale: IHH operates a vast network of hospitals and healthcare facilities across multiple countries, including Malaysia, Singapore, Turkey, India, and several others. This extensive footprint enables economies of scale, greater bargaining power with suppliers, and the ability to attract a larger patient base.
-
Strong Brand Recognition: The company has built a strong brand reputation over the years, particularly in markets like Singapore where it operates Singapore General Hospital and Mount Elizabeth Hospital. High standards of care and an established presence contribute to customer loyalty and preference.
-
Comprehensive Service Offerings: IHH provides a wide range of medical services across various specialties, including cardiology, orthopedics, oncology, and more. This comprehensive offering positions them as a one-stop healthcare provider, which can be appealing to patients who prefer continuity of care.
-
Focus on Quality and Safety: IHH places a strong emphasis on quality care and safety standards. The company has received various accreditations from reputable healthcare organizations, which enhances trust among patients and referring physicians.
-
Advanced Technology and Innovation: IHH invests heavily in state-of-the-art medical technology and innovations, which not only improves patient outcomes but also enhances operational efficiency. This technological edge can be a significant differentiator in attracting patients seeking advanced care options.
-
Strategic Partnerships and Collaborations: By forming strategic alliances with various healthcare organizations, IHH can expand its capabilities and access new markets. Such partnerships often enhance their service offerings and operational efficiencies.
-
Strong Financial Position: IHH's robust financial health allows it to invest in expanding its facilities, upgrading technology, and improving service offerings. A strong balance sheet also provides resilience in times of economic uncertainty.
-
Focus on Medical Tourism: IHH has effectively tapped into the medical tourism market, attracting international patients seeking high-quality care at competitive prices. Their locations in favorable regions enhance this advantage.
-
Talented Workforce: The company emphasizes hiring and retaining highly skilled medical professionals. A strong workforce leads to better patient care, attracting more patients and building a positive reputation.
-
Sustainability Initiatives: Increasingly, patients are considering the sustainability of healthcare providers. IHH's commitment to sustainable practices can appeal to environmentally conscious consumers.
These competitive advantages, when leveraged effectively, help IHH Healthcare Bhd differentiate itself from competitors and maintain a leading position in the healthcare sector.
IHH Healthcare Bhd, as one of Asia's largest healthcare providers, faces several risks and challenges that may impact its operations and growth prospects in the near future. Here are some key considerations:
1. Regulatory Changes
- Healthcare Regulations: Healthcare policies and regulations are subject to change, which can affect operational costs, compliance requirements, and service delivery.
- Licensing and Accreditation: Stricter licensing requirements and the need for continuous accreditation may impose additional burdens on operations.
2. Economic Environment
- Economic Downturns: Economic instability or recessions can lead to decreased patient volumes, especially in non-essential services.
- Currency Fluctuations: As an international player, IHH is exposed to foreign exchange risks impacting profitability from overseas operations.
3. Competitive Landscape
- Increased Competition: The healthcare sector is becoming increasingly competitive, with new entrants and growing local providers posing challenges to market share.
- Pricing Pressure: Competition can lead to pricing pressures, impacting profitability.
4. Operational Risks
- Quality of Care: Maintaining high standards of care and patient safety is essential. Any lapses can lead to reputational damage and legal liabilities.
- Supply Chain Disruptions: Ensuring a stable supply of medical supplies and pharmaceuticals is crucial, especially in a post-pandemic landscape.
5. Technological Advancements
- Failure to Adapt: The rapid pace of technological advancement in healthcare requires continuous investment in new technologies. Failure to adapt may impact competitiveness.
- Cybersecurity Risks: Increased reliance on digital healthcare solutions can expose the organization to cybersecurity threats.
6. Pandemic and Health Crises
- Ongoing Impact of COVID-19: The lingering effects of the pandemic continue to influence patient behavior, healthcare delivery models, and operational costs.
- Future Health Crises: Unforeseen health crises can strain resources and divert focus from core operations.
7. Human Resource Challenges
- Staff Shortages: The healthcare sector is facing a shortage of skilled professionals, which can impact service delivery.
- Workforce Retention: High turnover rates can lead to increased recruitment and training costs.
8. Public Perception and Trust
- Patient Trust: Building and maintaining trust is crucial in healthcare. Negative publicity or incidents can damage the brand’s reputation.
- Consumer Preferences: Shifts in consumer expectations and preferences, including demand for personalized care, can challenge existing service models.
9. Environmental and Social Governance (ESG) Issues
- Sustainability Practices: Increasing regulatory and public scrutiny on ESG practices requires IHH to adapt its operations to meet environmental and social responsibilities.
Conclusion
In summary, IHH Healthcare Bhd faces a complex array of risks and challenges that could influence its strategic direction and performance in the near future. Staying proactive in addressing these challenges, through effective risk management and strategic planning, will be crucial for sustained growth and competitiveness in the evolving healthcare landscape.
Revenue & Expenses Breakdown
IHH Healthcare Bhd
Balance Sheet Decomposition
IHH Healthcare Bhd
Current Assets | 6.7B |
Cash & Short-Term Investments | 2.7B |
Receivables | 3.1B |
Other Current Assets | 933.2m |
Non-Current Assets | 43.5B |
Long-Term Investments | 4.5B |
PP&E | 20.5B |
Intangibles | 17.3B |
Other Non-Current Assets | 1.2B |
Current Liabilities | 7.5B |
Accounts Payable | 5B |
Accrued Liabilities | 158.4m |
Short-Term Debt | 77.9m |
Other Current Liabilities | 2.3B |
Non-Current Liabilities | 13.6B |
Long-Term Debt | 8.1B |
Other Non-Current Liabilities | 5.6B |
Earnings Waterfall
IHH Healthcare Bhd
Revenue
|
23.2B
MYR
|
Cost of Revenue
|
-6.7B
MYR
|
Gross Profit
|
16.5B
MYR
|
Operating Expenses
|
-12.8B
MYR
|
Operating Income
|
3.7B
MYR
|
Other Expenses
|
-1B
MYR
|
Net Income
|
2.7B
MYR
|
Free Cash Flow Analysis
IHH Healthcare Bhd
MYR | |
Free Cash Flow | MYR |
IHH Profitability Score
Profitability Due Diligence
IHH Healthcare Bhd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
IHH Healthcare Bhd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
IHH Solvency Score
Solvency Due Diligence
IHH Healthcare Bhd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
IHH Healthcare Bhd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IHH Price Targets Summary
IHH Healthcare Bhd
According to Wall Street analysts, the average 1-year price target for IHH is 7.87 MYR with a low forecast of 6.95 MYR and a high forecast of 9.24 MYR.
Dividends
Current shareholder yield for IHH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
IHH Healthcare Bhd.is an investment holding company, which engages in the provision of healthcare services. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2012-04-02. The firm manages a portfolio of trusted healthcare brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai, Parkway and IMU in its key markets of Malaysia, Singapore, Turkey, India and Greater China (including Hong Kong). The firm operates through five segments: Parkway Pantai, which is a hospital operator and healthcare service provider in Asia; Acibadem Holdings, which is a hospital operator and healthcare service provider in Central Eastern Europe, the Middle East and North Africa and investment holding companies owning Acibadem Saglik Yatirimlari Holding A.S. (ASYH); IMU Health, which is an education service provider in Malaysia; PLife REIT, which is a real estate investment trust, and others segment, which includes the corporate office. The firm operates approximately 80 hospitals in over 10 countries.
Contact
IPO
Employees
Officers
The intrinsic value of one IHH stock under the Base Case scenario is 7.26 MYR.
Compared to the current market price of 7.19 MYR, IHH Healthcare Bhd is Undervalued by 1%.